Alzheimer's Disease

Showing NaN - NaN of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in New Haven, West Bend (BMS-984923, Placebo)

Recruiting
  • Alzheimer's Disease
  • New Haven, Connecticut
  • +1 more
Mar 27, 2023

Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +100 more
Oct 18, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Active, not recruiting
  • Alzheimer's Disease
  • Garden Grove, California
  • +48 more
Sep 1, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)

Recruiting
  • Alzheimer's Disease
  • Placebo
  • Bepranemab
  • Sun City, Arizona
  • +115 more
Aug 18, 2022

Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)

Recruiting
  • Alzheimer's Disease
  • Remternetug (IV)
  • +2 more
  • Chandler, Arizona
  • +70 more
Aug 10, 2022

Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

Recruiting
  • Alzheimer's Disease
  • Santa Ana, California
  • +19 more
Aug 9, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +132 more
Feb 16, 2022

Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +138 more
Dec 10, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Phoenix, Arizona
  • +180 more
Aug 9, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Birmingham, Alabama
  • +179 more
Aug 9, 2021

Alzheimer's Disease Trial in New Haven (saracatinib, Placebo)

Completed
  • Alzheimer's Disease
  • New Haven, Connecticut
    Yale Alzheimer's Disease Research Unit
Apr 22, 2021

Alzheimer's Disease Trial in United States (florbetapir F 18, Flortaucipir F18, Brain PET Scan)

Completed
  • Alzheimer's Disease
  • florbetapir F 18
  • +2 more
  • Phoenix, Arizona
  • +26 more
Sep 3, 2020

Alzheimer's Disease, Traumatic Brain Injury, Depression Trial in United States (Flortaucipir F18, Brain PET scan)

Completed
  • Alzheimer's Disease
  • +2 more
  • Flortaucipir F18
  • Brain PET scan
  • Phoenix, Arizona
  • +4 more
Aug 21, 2020

Alzheimer's Disease Trial in Newport Beach, New Haven (Flortaucipir F18, Brain PET scan)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • Brain PET scan
  • Newport Beach, California
  • +1 more
Aug 20, 2020

Apathy, Alzheimer's Disease Trial in Canada, United States (Methylphenidate, Placebo)

Completed
  • Apathy
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +9 more
Aug 7, 2020

Alzheimer's Disease Trial in New Haven (Flortaucipir F18)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • New Haven, Connecticut
    Molecular NeuroImaging
Jul 27, 2020

Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
  • Placebo
  • Tucson, Arizona
  • +31 more
Jul 31, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +195 more
Jul 1, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Terminated
  • Alzheimer's Disease
  • Newport Beach, California
  • +65 more
Jun 25, 2020

Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

Terminated
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Phoenix, Arizona
  • +134 more
May 15, 2020

Amnestic Mild Cognitive Impairment, Alzheimer's Disease Trial in United States (Insulin (Humulin® R U-100), Placebo)

Completed
  • Amnestic Mild Cognitive Impairment
  • Alzheimer's Disease
  • Insulin (Humulin® R U-100)
  • Placebo
  • Phoenix, Arizona
  • +24 more
May 14, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +85 more
Feb 18, 2020

Alzheimer's Disease Trial in United States ([18F]GTP1)

Completed
  • Alzheimer's Disease
  • New Haven, Connecticut
  • +15 more
Dec 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +261 more
Nov 19, 2019